Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based Study

NCT04440540 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped the patient recruitment was severely affected by COVID-19 pandemic

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

BEHAVIORAL: Dietitian led life style modification intervention
BEHAVIORAL: Conventional care (control)

Sponsor

Chinese University of Hong Kong